Parent site · placeholder
SPEC.04 · RETATRUTIDE · EDU ONLY

RETATRUTIDE

Retatrutide vial on white lab tile

A lab-made weekly peptide that hits three hunger and sugar switches at once: GLP-1, GIP and glucagon.

Most of the evidence◐ Reported
01

What it's made of

39Blocks
Y[Aib]QGTFTSDYSI[αMeL]LDK[K*]AQ[Aib]AFIEYLLEGGPSSGAPPPS
Lab-made block, not one of the 20FATFat tail: a fatty chain attached here makes it last about a week.

39 blocks, including 3 lab-made blocks that are not among the 20, plus a fatty tail that makes it last about a week.

Load it in the Peptide builder →
02

Where it comes from

Designed in a lab by Eli Lilly. The older weight-loss drugs hit one switch (semaglutide) or two (tirzepatide). Retatrutide adds a third: glucagon.

03

What it's studied for

  1. ● Proven in humans

    Weight loss: in the TRIUMPH-1 phase 3 trial (2,339 people, 80 weeks, published in NEJM in September 2026), average weight loss was 17.6% to 25.0% depending on dose, versus 3.9% on placebo.

  2. ● Proven in humans

    Type 2 diabetes: in TRIUMPH-2 (1,152 people, published in The Lancet in September 2026), weight loss was 11.9% to 18.8% depending on dose, versus 5.1% on placebo, and long-term blood sugar (A1C) fell by up to 1.6 points.

  3. ◐ Reported

    Liver fat: in a smaller phase 2 study (about 100 people, 48 weeks), fat inside the liver fell by about half, up to more than 80% at higher doses, versus about 5% on placebo.

  4. ◐ Reported

    Also being studied for knee osteoarthritis pain and sleep apnea.

Studied for ≠ proven to work. Check the stamp.

04

What we don't know

  1. ?

    The first two phase 3 papers came out in September 2026, in NEJM and The Lancet. Both trials were run and paid for by Lilly, and no heart outcomes trial has reported yet.

  2. ?
    ◐ Reported

    Heart safety: the number of serious heart events was similar to placebo (27 versus 23), but too small to be sure either way.

  3. ?

    Like other drugs in this family, stomach side effects such as nausea are common.

05

Status

  • Not approved anywhere yet. Lilly plans to file with the US FDA in early 2027.
  • Not registered in Vietnam.
  • The US FDA has warned people against buying it from unapproved sellers.
07

Words to know

Agonist = Something that switches a receptor on.Phase 3 = The large human trials that come right before a drug can be approved.A1C = A blood test that shows your average blood sugar over about 3 months.